AI tools for breast cancer detection fall short of radiologists' expectations

A survey of 215 members of the Society of Breast Imaging found that about half already use FDA-approved AI tools for breast cancer detection, but only 35 percent report lower recall rates, compared with 59 percent who had expected that outcome, highlighting a gap between expectations and real-world performance.

About half of 215 surveyed members of the Society of Breast Imaging already use FDA-approved AI tools for breast cancer detection, but the results fall short of expectations. Only 35 percent report lower recall rates, while 59 percent had expected them. The gap between promise and reality runs through every category measured. The article AI tools for breast cancer detection fall short of radiologists' expectations https://the-decoder.com/ai-tools-for-breast-cancer-detection-fall-short-of-radiologists-expectations/ appeared first on The Decoder https://the-decoder.com .